ACADIA Pharmaceuticals (ACAD)
(Delayed Data from NSDQ)
$18.75 USD
-0.39 (-2.04%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $18.76 +0.01 (0.05%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/06/2024
Time: AMC |
6/2024 | $0.16 | -17.46% |
Earnings Summary
For their last quarter, ACADIA Pharmaceuticals (ACAD) reported earnings of $0.10 per share, beating the Zacks Consensus Estimate of $0.04 per share. This reflects a positive earnings surprise of 150.00%. Look out for ACAD's next earnings release on August 06, 2024. For the next earning release, we expect the company to report earnings of $0.16 per share, reflecting a year-over-year increase of 1500%.
Earnings History
Price & Consensus
Zacks News for ACAD
Alnylam (ALNY) Soars 5.3%: Is Further Upside Left in the Stock?
ACAD: What are Zacks experts saying now?
Zacks Private Portfolio Services